
Home » Drug & Device Pipeline News
Drug & Device Pipeline News
Company | Drug/Device | Medical Condition | Status |
---|---|---|---|
Trials Authorized | |||
Cellevolve | CE-VST01-JC | Progressive multifocal leukoencephalopathy | IND approved by the FDA |
Cour Pharmaceuticals | CNP-106 | Myasthenia gravis | IND approved by the FDA |
Nihon Medi-Physics | NMK89 | Cancer diagnostic | IND approved by the FDA |
Trials Initiated | |||
Anixa Biosciences | Breast cancer vaccine | Breast cancer | Initiation of phase 1b trial |
Bio-Path Holdings | BP1002 | Refractory/relapsed acute myeloid leukemia | Initiation of phase 1/1b trial |
Corvus Pharmaceuticals | Ciforadenant plus ipilimumab and nivolumab | Metastatic renal cell cancer | Initiation of phase 1b/2 trial |
Sensorion | SENS-401 (arazasetron) | Cisplatin-induced ototoxicity | Initiation of a phase 2a trial in France |
Aphaia Pharma | APH-012 | Chronic weight management in people with obesity | Initiation of phase 2 trial |
Neurocrine Biosciences | NBI-1117568 | Schizophrenia in adults | Initiation of phase 2 trial |
Seelos Therapeutics | SLS-005 (trehalose injection) | Spinocerebellar ataxia type 3 | Initiation of phase 2/3 trial |
HUTCHMED | Fruquintinib plus sintilimab | Second-line treatment for locally advanced or metastatic renal cell carcinoma | Initiation of phase 2/3 trial in China |
Boehringer Ingelheim | BI 1015550 | Idiopathic pulmonary fibrosis | Initiation of phase 3 trial |
Codagenix | CoviLiv COVID-19 vaccine | COVID-19 | Initiation of phase 3 trial |
Finch Therapeutics | CP101 | Recurrent C. difficile infection | Initiation of phase 3 trial |
Approvals | |||
AbbVie | Rinvoq (upadacitinib) | Nonradiographic axial spondyloarthritis in adults | Approved by the FDA for new indication |
AstraZeneca | Imjudo (tremelimumab) plus Imfinzi (durvalumab) | Unresectable hepatocellular carcinoma in adults | Approved by the FDA |
Johnson & Johnson | Tecvayli (teclistamab-cqyv) | Relapsed or refractory multiple myeloma in adults | Approved by the FDA |

Upcoming Events
-
05Dec
-
14Apr